Explore 3 Stock Ideas & Industry Insights Download Free Report

Healthcare

Can Genedrive Plc Sustain Its Position in Biotechnology & Healthcare?

Genedrive Plc (GDR)Genedrive Plc develops point-of-care molecular diagnostics technology used for rapid testing in healthcare settings.

Ishan Mudgal | 13 July 2026

Can Ondine Biomedical, Inc. Sustain Its Position in Biotechnology & Healthcare?

Ondine Biomedical, Inc. (OBI)Ondine Biomedical, Inc. develops antimicrobial photodisinfection technology aimed at reducing hospital-acquired infections.

Ishan Mudgal | 13 July 2026

Is Provexis PLC Benefiting from Growing Health Awareness?

Provexis PLC (LSE:PXS) gained4.10%as investors showed renewed interest in healthcare and nutraceutical companies focused on preventive wellness solutions. Rising consumer awareness of heart health, functional nutrition and scientifically validated dietary ingredients supported buying activity. Positive sentiment toward health-focused businesses and defensive healthcare stocks also …

Ankur Sharma | 13 July 2026

Can Eroxon Continue Boosting Futura Medical's Growth?

LSE:FUMis a pharmaceutical company focused on developing and commercialising innovative topical treatments. Its lead product, Eroxon®, is an over-the-counter topical gel for the treatment of erectile dysfunction (ED), which has received regulatory approvals in several key international markets.

Ankur Sharma | 13 July 2026

Is Proteome Sciences plc Benefiting from Precision Medicine Growth?

Proteome Sciences plc (LSE:PRM) surged26.47%as investors showed strong interest in biotechnology companies operating in precision medicine and proteomics. Growing optimism surrounding life sciences innovation, increasing demand for biomarker research and improved sentiment across healthcare technology companies supported significant buying activity. The sharp upward move …

Ankur Sharma | 13 July 2026

Is Artificial Intelligence Accelerating Poolbeg Pharma's Growth?

Poolbeg Pharma PLC gained7.14%during today's trading session, making it one of the stronger-performing AIM-listed biotechnology stocks. The share-price rise appears to reflect improving investor sentiment toward life sciences companies, growing interest in artificial intelligence-driven drug development and optimism surrounding the company's expanding pharmaceutical pipeline.

Ankur Sharma | 13 July 2026

Why Did LSE:ONT Oxford Nanopore Shares Fall Today? China Weakness and Middle East Disruption Explained

Oxford Nanopore Technologies became one of the most actively discussed UK healthcare stocks after issuing a disappointing first-half trading update. While revenue continued to grow year-over-year, management admitted that performance fell below internal expectations, triggering a sharp sell-off in the shares.

Ankur Sharma | 13 July 2026

AOTI Shares Jump Higher: Why Is AOTI Stock Gaining Momentum?

• AOTI shares gained 4.00% on 13 July 2026, closing at 65.00 GBX.• AOTI, Inc. has a market capitalization of approximately 66.47 million GBP, placing it in the small-cap segment.• The company develops advanced wound care therapies and medical technologies for the treatment of …

Ankur Sharma | 13 July 2026

Renalytix Shares Decline: Why Is RENX Stock Under Pressure?

• RENX shares declined 7.14% on 13 July 2026, closing at 2.60 GBX.• Renalytix Plc has a market capitalization of approximately 12.24 million GBP, placing it in the micro-cap segment.• The company develops kidney disease diagnostics solutions using advanced data analytics and artificial intelligence …

Ankur Sharma | 13 July 2026

Chill Brands Shares Surge: Why Is CHLL Stock Attracting Investor Attention?

• CHLL shares gained 9.09% on 13 July 2026, closing at 2.40 GBX.• Chill Brands Group PLC has a market capitalization of approximately 1.15 million GBP, placing it in the micro-cap segment.• The company focuses on consumer wellness products and emerging healthcare-related markets.• Product …

Ankur Sharma | 13 July 2026
Support

Hi! How can we help you today?

Loading…